The Trendlines Group Ltd.

Equities

42T

IL0011328858

Investment Management & Fund Operators

Market Closed - Singapore S.E. Other stock markets 09:00:14 2024-05-01 pm EDT			5-day change	1st Jan Change
0.065 ^SGD	+4.84%		-5.80%	-28.57%

Mar. 27	Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million	MT
Feb. 22	Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023	MT

The Trendlines Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023

August 03, 2023 at 06:20 am EDT

The Trendlines Group Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was USD 12.41 million compared to negative revenue of USD 4.86 million a year ago. Net income was USD 4.54 million compared to net loss of USD 11.82 million a year ago.

Basic earnings per share from continuing operations was USD 0.0052 compared to basic loss per share from continuing operations of USD 0.0145 a year ago. Diluted earnings per share from continuing operations was USD 0.0052 compared to diluted loss per share from continuing operations of USD 0.0145 a year ago.

Latest news about The Trendlines Group Ltd.

Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million	Mar. 26	MT
Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023	Feb. 22	MT
Trendlines’ Attributable Net Loss Widens in H2 2023; Portfolio Value Decreases	Feb. 22	MT
Trendlines Co-Chair Steps Down; Interim Co-Chair Named	Feb. 22	MT
The Trendlines Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
The Trendlines Group Ltd. Announces Changes to the Composition of the Board and Its Committees, Effective 8 March 2024	Feb. 21	CI
The Trendlines Group Ltd. Announces Cessation of Kobby Greenberg as CEO Trendlines Innovation Labs	Feb. 13	CI
Trendlines Flags Wider FY2023 Loss After Cancelling Portfolio Acquisition	Feb. 05	MT
Singapore Stocks Lose Further Ground; Seatrium Shares Slip 2% on Cancelation of Wind Farm Project	Jan. 04	MT
Trendlines Group to Report Loss in 2023; Shares Drop 9%	Jan. 03	MT
The Trendlines Group Ltd. Provides Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2023	Jan. 03	CI
Transcript : The Trendlines Group Ltd. - Shareholder/Analyst Call	Nov. 14
The Trendlines Group Ltd. Appoints Haim Brosh as Interim Chief Financial Officer	23-10-31	CI
The Trendlines Group Ltd. Announces Chief Executive Officer Changes	23-10-31	CI
Trendlines Group's Portfolio Company Receives Letter of Intent for Acquisition	23-10-29	MT
Trendlines Group Issues Over 21 Million Shares Under Subscription Agreement	23-10-23	MT
The Trendlines Group Ltd. Announces Zeev Bronfeld to Retire as a Non-Executive Director	23-10-16	CI
ViAqua Therapeutics LTD. announced that it has received $8.25 million in funding from a group of investors	23-09-04	CI
Trendlines Group Issues Over 3.5 Million Shares Under Subscription Agreement	23-08-23	MT
Transcript : The Trendlines Group Ltd., Q2 2023 Earnings Call, Aug 14, 2023	23-08-14
The Trendlines Group Swings to Profit in H1	23-08-04	MT
The Trendlines Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-03	CI
Trendlines Group to Book Profit in H1; Shares Jump 3%	23-07-26	MT
The Trendlines Group Ltd. Provides Earning Guidance for Six Months Ended 30 June 2023	23-07-25	CI
Trendlines Group Places Over 17.5 Million Shares to Three Investors Under Subscription Agreement	23-07-12	MT

Chart The Trendlines Group Ltd.

Duration

Period

More charts

Company Profile

Trendlines Group Ltd is an Israel-based life sciences innovation commercialization company, which invents, discovers, invests in, partners and incubates innovation based medical and agricultural technologies. It invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Groupâ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.

Sector

Investment Management & Fund Operators

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
THE TRENDLINES GROUP LTD.	-28.57%	45.76M
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+15.78%	3.09B
HBM HEALTHCARE INVESTMENTS AG	+2.30%	1.4B
MOLTEN VENTURES PLC	+2.49%	663M
VERUSA HOLDING	+38.32%	616M
CION INVESTMENT CORPORATION	+1.59%	613M
OCTOPUS APOLLO VCT PLC	-4.17%	493M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+30.43%	473M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	305M

Venture Capital